Seeing Is Believing
Currently out of the existing stock ratings of Matthew Henriksson, 4 are a BUY (100%).
Analyst Matthew Henriksson, carries an average stock price target met ratio of 100% that have a potential upside of 17.02% achieved within 400 days. Previously, Matthew Henriksson worked at CITI.
Matthew Henriksson’s has documented 8 price targets and ratings displayed on 1 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on GMED, Globus Medical at 05-Aug-2021.
Analyst best performing recommendations are on GMED (GLOBUS MEDICAL).
The best stock recommendation documented was for GMED (GLOBUS MEDICAL) at 2/18/2021. The price target of $77 was fulfilled within 127 days with a profit of $13.5 (21.26%) receiving and performance score of 1.67.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 28-Jul-2026
$82
$-4.91 (-5.65%)
$85
Buy Since 18-Nov-2025
$100
$13.09 (15.06%)
$105
Buy Since 09-Dec-2021
$115
$28.09 (32.32%)
$120
Buy Since 06-Nov-2024
$100
$13.75 (15.94%)
$115
Buy Since 25-Feb-2026
$117
$30.75 (35.65%)
$114
What Year was the first public recommendation made by Matthew Henriksson?